Literature DB >> 8409763

Characterization of cholesteryl ester transfer protein inhibitor from plasma of baboons (Papio sp.).

R S Kushwaha1, S Q Hasan, H C McGill, G S Getz, R G Dunham, P Kanda.   

Abstract

Selective breeding has produced families of baboons that accumulate large high density lipoproteins (HDL1) when challenged with a high cholesterol and high fat (HCHF) diet. In the plasma isolated from these high HDL1 baboons there is a factor that decreases the transfer of cholesteryl ester from HDL to lower density lipoproteins. The purpose of these studies was to identify and characterize this inhibitor of cholesteryl ester transfer. A protein with molecular mass of approximately 4 kDa was detected in greater amounts in the plasma lipoproteins of high HDL1 baboons fed the HCHF diet than in plasma lipoproteins of low HDL1 baboons. This 4 kDa protein appeared to associate with apolipoprotein (apo) A-I, resulting in modified apoA-I with an apparent molecular mass of 31 kDa. A small amount of modified apoE was also identified with a molecular mass of 41 kDa. N-terminal amino acid sequencing of the 4 kDa peptide identified it as an N-terminal fragment of apoC-I. Like apoC-I, the fragment is also a slightly basic protein (pI 7.1). The apoC-I fragment and modified apoA-I presented at equimolar concentrations exhibited similar inhibition of cholesteryl ester transfer protein (CETP) activity in HDL of low HDL1 baboons. On the basis of baboon apoC-I amino acid sequence and the molecular mass of the inhibitor peptide, a peptide corresponding to the N-terminal 38 amino acids of apoC-I was synthesized chemically. This synthetic peptide also inhibited CETP activity in vitro. Rabbit polyclonal antisera prepared against the 38 amino acid synthetic peptide recognized the 4 kDa molecular mass inhibitor protein, apoC-I (6.6 kDa), and the modified apoA-I protein (31 kDa molecular mass) in the plasma lipoproteins of high HDL1 baboons. On the other hand, the antibody detected only apoC-I in the plasma lipoproteins of low HDL1 baboons. The IgG fraction isolated from antiserum raised against the synthetic inhibitor peptide increased cholesteryl ester transfer from HDL of high HDL1 baboons, whereas the IgG antibody against CETP decreased cholesteryl ester transfer from HDL of both high and low HDL1 baboons. These studies suggest that the CETP inhibitor is an N-terminal fragment of apoC-I, and this fragment also modifies apoA-I and apoE in the plasma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409763

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

Review 1.  Baboons as a model to study genetics and epigenetics of human disease.

Authors:  Laura A Cox; Anthony G Comuzzie; Lorena M Havill; Genesio M Karere; Kimberly D Spradling; Michael C Mahaney; Peter W Nathanielsz; Daniel P Nicolella; Robert E Shade; Saroja Voruganti; John L VandeBerg
Journal:  ILAR J       Date:  2013

2.  Conformational studies of the N-terminal lipid-associating domain of human apolipoprotein C-I by CD and 1H NMR spectroscopy.

Authors:  A Rozek; G W Buchko; P Kanda; R J Cushley
Journal:  Protein Sci       Date:  1997-09       Impact factor: 6.725

3.  Proteogenomic Review of the Changes in Primate apoC-I during Evolution.

Authors:  Donald Puppione; Julian P Whitelegge
Journal:  Front Biol (Beijing)       Date:  2013-10-02

4.  Structural studies of a baboon (Papio sp.) plasma protein inhibitor of cholesteryl ester transferase.

Authors:  G W Buchko; A Rozek; P Kanda; M A Kennedy; R J Cushley
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

5.  Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.

Authors:  A Inazu; X C Jiang; T Haraki; K Yagi; N Kamon; J Koizumi; H Mabuchi; R Takeda; K Takata; Y Moriyama
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.

Authors:  Thomas Gautier; David Masson; Miek C Jong; Jean-Paul Pais de Barros; Linda Duverneuil; Naig Le Guern; Valérie Deckert; Laure Dumont; Amandine Bataille; Zoulika Zak; Xian-Cheng Jiang; Louis M Havekes; Laurent Lagrost
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

7.  Identifying blood biomarkers and physiological processes that distinguish humans with superior performance under psychological stress.

Authors:  Amanda M Cooksey; Nausheen Momen; Russell Stocker; Shane C Burgess
Journal:  PLoS One       Date:  2009-12-18       Impact factor: 3.240

8.  Interaction of CETP inhibitory peptide and lipoprotein substrates in cholesteryl ester transfer assay: relationship between association properties and inhibitory activities.

Authors:  Kyung-Hyun Cho; Ju-Young Lee; Myung-Sook Choi; Song-Hae Bok; Yong Bok Park
Journal:  Lipids       Date:  2002-07       Impact factor: 1.880

9.  Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

Authors:  Nicole E B Skinner; Matthew S Wroblewski; Julie A Kirihara; Gary L Nelsestuen; Elizabeth R Seaquist
Journal:  Diabetes Ther       Date:  2015-07-22       Impact factor: 2.945

10.  Effect of Synthetic Truncated Apolipoprotein C-I Peptide on Plasma Lipoprotein Cholesterol in Nonhuman Primates.

Authors:  Rampratap S Kushwaha; Henry C McGill; Frederick H Hausheer
Journal:  J Biomed Biotechnol       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.